ARCHIVES

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

This article is from The Cancer Letter archive.

Vol. 32 No. 29 | July 28, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Three Patients Evaluated For Gene Therapy; Revised Program Instructions Available

November 30, 1990

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

January 12, 1979

Chaos In Congress Killed $20 Million Increase For NCI

December 19, 1980

Nominations Sought For Paul Marks Prizes, Recognizing Discoverise By The Under-45 Set.

April 13, 2001

NIEHS Director Olden Outlines Strategy For Carcinogenicity Testing

September 11, 1992

CCOP Summary Statements Soon To Be Available

April 22, 1983